Court Awards 'Unprecedented' $6M in Attorneys’ Fees

In a Nexium class action against AstraZeneca Pharmaceuticals, Justice Sanders awarded $6 million in attorneys’ fees—30% of the $20 million common fund agreed to in a settlement achieved shortly before trial. Justice Sanders acknowledged that this was an “unprecedented” award for state court, but believed it was warranted by the facts of this case.

Commonwealth Care Alliance and Crenshaw v. Astrazeneca Pharmaceuticals, L.P.

Full decision here.

Blog Editors

Recent Posts

Back to Page